-
#Tumore della#prostata: parere positivo del#CHMP per#darolutamide: Il Comitato per i…https://goo.gl/fb/XLSFRV -
.
@abbvie recibe la opinión positiva del#CHMP para#Venclyxto como la primera combinación sin quimioterapia para pacientes con#leucemia linfocítica crónica no tratada previamente http://ow.ly/3dGw50yd4NZ pic.twitter.com/R6ld0rndXR
-
El
#CHMP recomienda aprobación de la nueva#insulina prandial para el control glucémido en adultos con#diabeteshttps://www.immedicohospitalario.es/noticia/18368/el-chmp-recomienda-aprobacion-de-la-nueva-insulina-prandial-para-el-c … -
Update uit Europa: o.a. 15 nieuwe medicijnen voor goedkeuring naar de
@EU_Commission gestuurd, waaronder 1e medicijn tegen acute hepatische#porfyrie (stofwisselingsziekte) en 1e orale vorm van semaglutide (behandeling diabetes type 2).#CHMP@EMA_News https://bit.ly/2OnNXMO pic.twitter.com/rSV9ZsHbnB
-
Good news for
#MedsForKids!#CHMP recommends licence extensions for pts 12-18 yrs for: - Rezolsta (darunavir/cobicistat) for HIV: https://buff.ly/3b6A4g4 - Tybost (cobicistat) for HIV: https://buff.ly/3b3cJM6 - MabThera (rituximab) for several indications:https://buff.ly/2RTM3pJ -
Cinacalcet goes generic!
#CHMP positive opinion for Accord Pharma's generic of Mimpara: watch out for grant of licence soon. https://buff.ly/36X5S3n -
Semaglutide:
#CHMP recommends licensing an oral version. Not licensed yet, but look out for it soon!#diabeteshttps://buff.ly/2uVspAC -
#AbbVie Receives Positive#CHMP Opinion for#VENCLYXTO® as a#Chemotherapy-Free Combination Regimen for Patients with Previously Untreated#ChronicLymphocyticLeukemia$ABBV https://www.1stoncology.com/blog/abbvie-receives-positive-chmp-opinion-for-venclyxto-as-a-chemotherapy-free-combination-regimen-for-patients-with-previously-untreated-chronic-lymphocytic-leukemia1234553735 … -
Pleased to share that the EMA’s Committee for Medicinal Products for Human Use (
#CHMP) issued a positive opinion for our mild to moderate#atopicdermatitis treatment.#eczemapic.twitter.com/tHAebateAz
-
@EMA_News’ human medicines committee (#CHMP) recommends approval of our new fast-acting mealtime insulin for the treatment of#diabetes. Learn more:https://e.lilly/3aYnvDp -
#Pharmazieschlagzeile@cashch Der Pharma- und Agrarchemiekonzern@Bayer kann für sein Krebsmedikament#Darolutamid zur Behandlung von#Prostatakrebs auf die Zulassung in der EU hoffen.#CHMP#nmCRPC@OrionPharmahttps://www.cash.ch/news/boersenticker-firmen/bayer-kann-auf-zulassung-des-krebs-mittels-darolutamid-der-eu-hoffen-1472095 … -
#Oncology News: We received a positive#CHMP opinion for a potential treatment for patients with chronic lymphocytic leukemia. Learn more: http://bit.ly/37NaN8r#CLLpic.twitter.com/lzkK9ZLyHC
-
#NEWS: New treatment for men with#nmCRPC from#Bayer receives positive#CHMP opinion http://bit.ly/News_Bayer -
First oral GLP-1 treatment for type 2
#diabetes recommended for approval. It provides patients with an option to treat the disease without injections https://www.ema.europa.eu/en/news/first-oral-glp-1-treatment-type-2-diabetes …#CHMP -
First treatment for
#AcuteHepaticPorphyria, a rare life-threatening genetic condition, recommended for approval https://www.ema.europa.eu/en/news/first-treatment-acute-hepatic-porphyria …#CHMP -
EMA’s human medicines committee (
#CHMP) recommends 15#medicines for approval at its January 2020 meeting: https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-january-2020 …pic.twitter.com/xqCDIRAAYr
-
We’re pleased to announce that we’ve received a positive opinion from the EMA (
@EMA_News) Committee for Medicinal Products for Human Use (#CHMP) for our investigational#RNAi therapeutic for the treatment of the#raredisease acute hepatic#porphyria.
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.